Evidence map›Paper›PMID 22945240›Full record

ReviewHeart failure reviews2013

(1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism.

Kiterie M E Faller, Craig A Lygate, Stefan Neubauer, Jürgen E Schneider

Open access · hybridAbstract readReview
In one paragraph

Review in Heart failure reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Water-suppression cycling 3-T cardiacNMR in biomedicine · 2021
    Article
  8. Comparison of single-voxelJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Article
  9. Diabetic heart disease: A clinical update.World journal of diabetes · 2021
    Review
  10. Article
  11. Article
  12. Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2019
    Article
  13. Non-Water-SuppressedScientific reports · 2017 · on this map
    Article
  14. La Radiologia medica · 2017
    Article
  15. Article
  16. The Flexibility of Ectopic Lipids.International journal of molecular sciences · 2016
    Review
  17. Observational
  18. The Potential of Metabolic Imaging.Seminars in nuclear medicine · 2016
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kiterie M E FallerDepartment of Cardiovascular Medicine, British Heart Foundation Experimental Magnetic Resonance Unit (BMRU), Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.
Craig A Lygate
Stefan Neubauer
Jürgen E Schneider
Centre for Human Genetics · GBBritish Heart Foundation · GBUniversity of Oxford · GB

Funding

British Heart Foundation BS/06/001British Heart Foundation FS/07/065British Heart Foundation FS/11/50/29038British Heart Foundation PG/05/115British Heart Foundation RG/10/002/28187British Heart Foundation RG/13/8/30266Wellcome Trust 090532Wellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

Magnetic resonance spectroscopy (MRS) is the only non-invasive, non-radiation-based technique for investigating the metabolism of living tissue. MRS of protons (1H-MRS), which provides the highest sensitivity of all MR-visible nuclei, is a method capable of detecting and quantifying specific cardiac biomolecules, such as lipids and creatine in normal and diseased hearts in both animal models and humans. This can be used to study mechanisms of heart failure development in a longitudinal manner, for example, the potential contribution of myocardial lipid accumulation in the context of ageing and obesity. Similarly, quantifying creatine levels provides insight into the energy storage and buffering capacity in the heart. Creatine depletion is consistently observed in heart failure independent of aetiology, but its contribution to pathophysiology remains a matter of debate. These and other questions can in theory be answered with cardiac MRS, but fundamental technical challenges have limited its use. The metabolites studied with MRS are much lower concentration than water protons, requiring methods to suppress the dominant water signal and resulting in larger voxel sizes and longer scan times compared to MRI. However, recent technical advances in MR hardware and software have facilitated the application of 1H-MRS in humans and animal models of heart disease as detailed in this review.

Indexed as

Lipid MetabolismAnimalsCreatineHeart DiseasesHumansLipidsMagnetic Resonance SpectroscopyMyocardiumCreatineLipids

Identifiers

PMID22945240
PMCPMC3782658
OpenAlexW1965246865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.